09:26 AM EDT, 05/31/2024 (MT Newswires) -- Johnson & Johnson ( JNJ ) said Friday that it has closed its acquisition of Shockwave Medical, which it said will operate as a business unit within Johnson & Johnson MedTech.

The transaction is anticipated to dilute adjusted earnings per share by about $0.10 in 2024 and $0.17 in 2025 considering the impact of funding costs, the company said.

Following completion of the deal, Shockwave Medical's common stock ceased trading on Nasdaq.

Price: 145.50, Change: +0.22, Percent Change: +0.15